Skip to main content

Want a detailed portfolio tracker?

Ideaya Biosciences (IDYA) P/E (2019 - 2026)

Ideaya Biosciences (IDYA) P/E from Jul 1, 2019 to Jul 21, 2026. The TTM Ideaya Biosciences (IDYA) P/E is -22.58. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ideaya Biosciences (IDYA)

YearP/EChange
2026-22.58-15.31%
2025-26.66+245.35%
2024-7.72-57.80%
2023-18.29+38.08%
2022-13.25-22.40%
2021-17.07+69.61%
2020-10.07+114.16%
2019-4.70N/A

Comparison Ideaya Biosciences (IDYA) P/E with competitors

Ideaya Biosciences (IDYA) P/E is -22.58.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.33%
FGENFibroGen Inc0.24-101.06%
CHRSCoherus Biosciences Inc0.85-103.76%
FBIOFortress Biotech Inc0.95-104.20%
ORMPOramed Pharmaceuticals Inc1.50-106.66%
AGENAgenus Inc3.01-113.33%
INVAInnoviva Inc3.15-113.97%
VXRTVaxart Inc3.55-115.72%
CRMDCorMedix Inc3.63-116.07%
CVACCureVac N.V.4.45-119.69%
GLPGGalapagos NV4.86-121.52%
SRPTSarepta Therapeutics Inc4.88-121.62%
ABEOAbeona Therapeutics Inc5.39-123.86%
ABUSArbutus Biopharma Corp5.60-124.78%
ZVRAZevra Therapeutics Inc5.89-126.07%
SPROSpero Therapeutics Inc6.23-127.59%
CGENCompugen Ltd6.31-127.96%
RIGLRigel Pharmaceuticals6.87-130.44%
SLXNSilexion Therapeutics Corp7.30-132.31%
OMEROmeros Corporation9.26-141.01%
AUPHAurinia Pharmaceuticals Inc9.58-142.45%
PLXProtalix BioTherapeutics Inc10.89-148.24%
ACADAcadia Pharmaceuticals Inc11.73-151.95%
TBPHTheravance Biopharma Inc12.26-154.31%
ADMAAdma Biologics Inc12.42-155.00%
HRMYHarmony Biosciences Holdings Inc13.82-161.21%
SABSSAB Biotherapeutics Inc14.14-162.61%
NAGENiagen Bioscience Inc14.82-165.63%
INCYIncyte Corp15.82-170.08%
REGNRegeneron Pharmaceuticals Inc15.86-170.23%
PBYIPuma Biotechnology Inc17.32-176.69%
CPRXCatalyst Pharmaceuticals Inc17.44-177.24%
EXELExelixis Inc17.54-177.68%
TGTXTG Therapeutics Inc18.97-184.00%
MDXGMimedx Group Inc20.55-191.03%
XOMAXOMA Royalty Corp22.87-201.32%
ARGXArgen X SE24.30-207.62%
CTMXCytomX Therapeutics Inc24.82-209.94%
XOMAOXOMA Royalty Corp25.34-212.26%
HALOHalozyme Therapeutics Inc25.62-213.49%
XOMAPXOMA Royalty Corp25.67-213.70%
VRTXVertex Pharmaceuticals Inc27.99-223.99%
RPRXRoyalty Pharma plc - Class A28.69-227.06%
SLNOSoleno Therapeutics Inc29.02-228.51%
ASNDAscendis Pharma A/S30.09-233.25%
LGNDLigand Pharmaceuticals Inc - Class B37.91-267.92%
APLSApellis Pharmaceuticals Inc39.02-272.83%
BMRNBiomarin Pharmaceutical Inc42.21-286.96%
KRYSKrystal Biotech Inc45.34-300.83%
ONCBeiGene Ltd69.54-408.00%
PHARPharming Group N.V.75.03-432.30%
TECHBio-Techne Corp101.96-551.59%
VCELVericel Corp109.92-586.86%
ALNYAlnylam Pharmaceuticals Inc117.96-622.48%
GMABGenmab140.29-721.37%
TLXTelix Pharmaceuticals Ltd162.15-818.20%
CORTCorcept Therapeutics Inc212.86-1042.78%